Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.305,56
0,10%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Viking Therapeutics Inc (VKTX) Viking Therapeutics Inc (VKTX) Notizie

Viking Therapeutics Inc

VKTX
42,9499
1,83 (4,45%)
04 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/11/202422:03PRNUSViking Therapeutics Presents Results from Phase 2b VOYAGE..
12/11/202422:05PRNUSViking Therapeutics to Present Data from Phase 2b VOYAGE..
04/11/202412:31EDGAR2Form 8-K - Current report
04/11/202412:30PRNUSViking Therapeutics Reports New Data from VK2735 Obesity..
04/11/202412:20IHMARKETNEWSTesla Sales Drop; Intel to Exit Dow Jones After 25 Years;..
31/10/202421:05PRNUSViking Therapeutics to Participate at Upcoming Investor..
28/10/202421:05PRNUSViking Therapeutics to Highlight Clinical Data from VK2735..
26/10/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202422:10EDGAR2Form 144 - Report of proposed sale of securities
24/10/202412:07IHMARKETNEWSTesla Shares Rise 11% Pre-Market; IBM Falls 4% on..
23/10/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/10/202422:09EDGAR2Form 8-K - Current report
23/10/202422:05PRNUSViking Therapeutics Reports Third Quarter 2024 Financial..
23/10/202411:58IHMARKETNEWSUS Futures Fall Amid Treasury Yield Surge and Earnings; Oil..
16/10/202422:05PRNUSViking Therapeutics to Report Financial Results for Third..
10/10/202412:45IHMARKETNEWSTesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits;..
09/10/202413:00PRNUSViking Therapeutics Announces Results from Phase 1b Clinical..
21/9/202403:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202422:29EDGAR2Form 144 - Report of proposed sale of securities
28/8/202422:03PRNUSViking Therapeutics to Participate at Morgan Stanley 22nd..
23/8/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:30EDGAR2Form 144 - Report of proposed sale of securities
20/8/202402:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202402:00EDGAR2Form 144 - Report of proposed sale of securities
31/7/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202423:56EDGAR2Form 144 - Report of proposed sale of securities
30/7/202423:55EDGAR2Form 144 - Report of proposed sale of securities
25/7/202412:19IHMARKETNEWSEarnings Updates: Ford Shares Fall 13% on EPS Miss,..
24/7/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/7/202422:10EDGAR2Form 8-K - Current report
24/7/202422:05PRNUSViking Therapeutics Reports Second Quarter 2024 Financial..
24/7/202411:55IHMARKETNEWSUS Index Futures Fall Amid Tech Giant Earnings, Oil Prices..
17/7/202422:05PRNUSViking Therapeutics to Report Financial Results for Second..
24/6/202413:33PRNUSViking Therapeutics Presents Preclinical Data on Novel Dual..
04/6/202413:10EDGAR2Form 8-K - Current report
04/6/202413:05PRNUSViking Therapeutics Announces Positive 52-Week Histologic..
30/5/202422:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
22/5/202423:12EDGAR2Form S-8 POS - Securities to be offered to employees in..
22/5/202422:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
24/4/202422:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial..
24/4/202413:31IHMARKETNEWSU.S. Futures Display Mixed Results Amid Earnings, WTI and..
17/4/202422:05PRNUSViking Therapeutics to Report Financial Results for First..
26/3/202412:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
05/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:52EDGAR2Form 8-K - Current report
04/3/202422:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
01/3/202422:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202402:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
27/2/202423:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 41,38 Min: 41,30 Max: 42,95
Chiusura: 41,12

La tua Cronologia

NASDAQ
VKTX
Viking Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network